India, Sept. 29 -- Pharma major Lupin announced on Monday that its wholly owned subsidiary Nanomi BV has signed a definitive agreement to acquire Amsterdam-headquartered VISUfarma BV for an enterprise value of €190 million.
VISUfarma, a portfolio company of global healthcare investor GHO Capital Partners LLP, has a broad portfolio of eye health products and a well-established commercial infrastructure across Europe. Lupin said the acquisition strengthens its European presence and supports its strategy to expand its global specialty franchise.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....